Intrinsic Value of S&P & Nasdaq Contact Us

Clene Inc. CLNN

NASDAQ Capital Marke

SharesGrow Score
36/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$50.00
+649.1%

Clene Inc. (CLNN) current share price is $6.68. The gold spot price is $4,825.20 per troy ounce. Using the formula: CLNN in gold = $6.68 × 31.1035 ÷ $4,825.20 = 0.0430 grams of gold per share.

The Real Wealth Growth Rate measures the Compound Annual Growth Rate (CAGR) of CLNN when denominated in gold. A positive rate means the stock has outperformed gold as a store of value, while a negative rate indicates gold has been a better wealth preserver than holding CLNN shares over the measured period.

CLNN in US Dollars
Gold in US Dollars
CLNN in Gold (grams per share)

Real Wealth Growth Rate

CLNN
Computing…

"Real Wealth Growth Rate" measures the annualised compound growth rate (CAGR) of a stock when priced in gold — hard money that cannot be printed. A positive value means genuine wealth creation. A negative value means purchasing power is shrinking, even if the dollar price rises.

Step 1 — Express share price in grams of gold
$$\text{CLNN}_{\text{gold}}(t) = \frac{P_{\text{CLNN}}(t) \times 31.1035}{P_{\text{gold}}(t)}$$
$P_\text{CLNN}$ = stock price in USD, $P_\text{gold}$ = gold spot in USD/troy oz, $31.1035$ = grams per troy ounce.
Step 2 — Real Wealth Growth Rate (CAGR in gold terms)
$$\text{Real Wealth Growth Rate} = \left(\frac{\text{CLNN}_{\text{gold}}^{(T)}}{\text{CLNN}_{\text{gold}}^{(0)}}\right)^{\!\frac{1}{T}} - 1$$
$\text{CLNN}_\text{gold}^{(0)}$ = initial gold-price, $\text{CLNN}_\text{gold}^{(T)}$ = current gold-price, $T$ = number of years. A positive result means the stock outpaces gold.

Real Wealth Growth Rate Rankings — 20 Years

Computing…

People Also View

IMNM
IMNM
Immunome, Inc.
$22.90
+1.24%
MLYS
MLYS
Mineralys Therapeutics, Inc.
$27.32
+0.59%
NUVB
NUVB
Nuvation Bio Inc.
$4.85
+3.19%
IKNA
IKNA
Ikena Oncology, Inc.
$17.16
+1,152.55%
ELYM
ELYM
Eliem Therapeutics, Inc.
$5.11
-0.97%
FHTX
FHTX
Foghorn Therapeutics Inc.
$4.85
+3.41%
MACK
MACK
Merrimack Pharmaceuticals, Inc.
$15.15
+0.10%
IPSC
IPSC
Century Therapeutics, Inc.
$2.37
+4.41%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message